Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05960890 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cohort Study of Chronic Heart Failure

Study acronym: CHF
StatusRecruiting
PhaseNot applicable
Started2023-06-08
View on ClinicalTrials.gov ↗

Amendment history

2026-05-18
minor
Study Status, Oversight, References v2
Primary completion date2025-12→2028-12
Completion date2026-12→2028-12
2025-05-29
minor
Study Status, Oversight, Study Design, Arms and Interventions, Outcome Measures, Eligibility v1
PhaseNot specified→Not applicable
Eligibility criteria+302 characters
Inclusion Criteria: OverAge ≥18 years; Fulfill oldat least one of the following criteria:①History of chronic heart failure;②New-onset heart failure with LVEF <50%;③New-onset heart failure with LVEF≧50%,E/e'≧15 and BNP>400 pg/mL/NT-proBNP(<50 years, >450 pg/mL; 50~75 years, >900 pg/mL; >75 years, >1800 pg/mL) DilatedEtiology: dilated cardiomyopathy, hypertensive heart disease, ischaemic cardiomyopathy, ischemic cardiomyopathy (coronary heart disease), nonNon-severe valvular heart disease; LVEF<50%,Primary and/orpost-discharge NT-proBNP>1800ng/L,therapy: and/ororal BNP>100ng/L,medication; Sign N [...] [...]
Primary endpoints1 entry, revised
Composite endpointincidence of composite event (cardiovascular deathmortality, andunplanned rehospitalizationHF forhospitalization, heartemergency failureHF intervention)
2023-07-23
minor
Original filing
The goal of this observational study is to learn about the influencing factors of chronic heart failure prognosis in heart failure patients. The main question it aims to answer is that what are the influencing factors of clinical outcomes in chronic heart failure. Participants will be collected multiple omics data such as phenotype group, environmental exposure group, intestinal microbiome, genome, metabolome, and noninvasive biomarkers.
Trial Details
NCT Number NCT05960890
Lead Sponsor Jiangsu Taizhou People's Hospital
Conditions Heart Failure
Enrollment 1,000 participants
Start Date 2023-06-08
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-20